2022 annual financial data
China SXT Pharmaceuticals 2022 Operating margin
China SXT Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -199.43%.
Operating income was -5,189,673 USD and net income was -5,736,095 USD.
Operating cash flow was -2,374,531 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,602,281 USD
- Operating income
- -5,189,673 USD
- Net income
- -5,736,095 USD
- Operating cash flow
- -2,374,531 USD